.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
McKinsey
Accenture
Farmers Insurance
Cipla
Baxter
Colorcon
Boehringer Ingelheim
Novartis
Argus Health

Generated: September 24, 2017

DrugPatentWatch Database Preview

BLEPHAMIDE Drug Profile

« Back to Dashboard

Which patents cover Blephamide, and when can generic versions of Blephamide launch?

Blephamide is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in BLEPHAMIDE is prednisolone acetate; sulfacetamide sodium. There are eighty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.

Summary for Tradename: BLEPHAMIDE

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BLEPHAMIDE at DailyMed

Pharmacology for Tradename: BLEPHAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
BLEPHAMIDE
prednisolone acetate; sulfacetamide sodium
SUSPENSION;OPHTHALMIC012813-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Allergan
BLEPHAMIDE S.O.P.
prednisolone acetate; sulfacetamide sodium
OINTMENT;OPHTHALMIC087748-001Dec 3, 1986RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Accenture
Queensland Health
Colorcon
Citi
Federal Trade Commission
McKesson
Farmers Insurance
Baxter
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot